These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 11008250)
1. Commentary on 'New adjuvant therapy for colon Cancer' by galanis et al. Greeno EW Surg Oncol Clin N Am; 2000 Oct; 9(4):825-6. PubMed ID: 11008250 [No Abstract] [Full Text] [Related]
2. Commentary on 'Laparoscopic resection for colorectal Cancer' by lee et al. Karulf RE Surg Oncol Clin N Am; 2000 Oct; 9(4):783-4. PubMed ID: 11008244 [No Abstract] [Full Text] [Related]
3. Commentary on 'Colorectal Cancer' by rodriguez-bigas et al. Finne CO Surg Oncol Clin N Am; 2000 Oct; 9(4):653-4. PubMed ID: 11008228 [No Abstract] [Full Text] [Related]
4. Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses. Viale PH Oncol Nurs Forum; 2006 Jan; 33(1):81-90. PubMed ID: 16470236 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51. Cancer Treat Rev; 2004 Dec; 30(8):711-3. PubMed ID: 15541581 [No Abstract] [Full Text] [Related]
6. Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions : commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039-3045, 2002. Coffey DS Clin Cancer Res; 2002 Oct; 8(10):3031-3. PubMed ID: 12374668 [No Abstract] [Full Text] [Related]
7. Adjuvant therapy of colon cancer: current status and future directions. Chung KY; Saltz LB Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769 [TBL] [Abstract][Full Text] [Related]
8. Commentary on 'Current protocols and outcomes of local therapy for rectal Cancer' by bleday and steele. Garcia-Aguilar J Surg Oncol Clin N Am; 2000 Oct; 9(4):759-61. PubMed ID: 11008242 [No Abstract] [Full Text] [Related]
9. Correspondence re Yuan JM et al., Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. 2001;10:767-73. Neuhoser ML et al., Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). 2002;12:350-8. Satia-Abouta J et al., Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. 2003;12:747-54. Ruano-Ravina A; Barros-Dios JM; Figueiras A; Brañas-Tato P Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):679-80; author reply 680. PubMed ID: 15066939 [No Abstract] [Full Text] [Related]
10. Discussion: 'Biomarkers for detection of early ovarian cancer' by Nosov et al. Massad LS; Parks L; Rimel BJ; Kizer N; Ogutha J Am J Obstet Gynecol; 2009 Jun; 200(6):e1-3. PubMed ID: 19482110 [No Abstract] [Full Text] [Related]
12. Claims of a 'new' stuttering treatment using time-out from speaking are exaggerated: a brief review of the literature and commentary on Hewat et al. (2006). James JE Disabil Rehabil; 2007 Jul; 29(13):1057-60. PubMed ID: 17612991 [TBL] [Abstract][Full Text] [Related]
13. Commentary on 'Hormone replacement therapy use and variations in the risk of breast cancer'. Suissa S; Opatrny L BJOG; 2008 Jun; 115(7):918. PubMed ID: 18485173 [No Abstract] [Full Text] [Related]
14. Commentary on: Mobley AJ, Lam YW, Lau KM, Pais VM, Lesperance JO, Steadman B, et al. Monitoring the serological Proteome Colon, the latest modality in prostate cancer detection. J Urol 2004; 172: 331-7. Getzenberg RH Asian J Androl; 2004 Dec; 6(4):283. PubMed ID: 15546017 [No Abstract] [Full Text] [Related]
16. Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer. Sanguineti G; Forastiere AA Nat Clin Pract Oncol; 2008 Dec; 5(12):694-5. PubMed ID: 18825140 [TBL] [Abstract][Full Text] [Related]
17. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
18. Commentary on Liu et al. (2008) A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer. Journal of Clinical Nursing 17, 2539-2549. Erceg-Hurn D J Clin Nurs; 2009 Jun; 18(11):1660-1. PubMed ID: 19490302 [No Abstract] [Full Text] [Related]
19. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: a commentary. Abrams J J Clin Oncol; 2005 Dec; 23(34):8564-5. PubMed ID: 16260691 [No Abstract] [Full Text] [Related]
20. New approaches to the adjuvant therapy of colon cancer. Benson AB Oncologist; 2006 Oct; 11(9):973-80. PubMed ID: 17030637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]